Abbisko taps Hong Kong IPO market for $225m

Biopharmaceutical firm Abbisko kicked off bookbuilding for its Hong Kong IPO on Thursday, aiming to raise HK$1.75bn ($225.2m). The Shanghai-based company specialises in the discovery and development ... ( read original story ...)

Hong Kong: Passage of fund bills welcomed

He said the two bills’ passage would spur the rapid development of Hong Kong’s asset and wealth management business. The amended ordinances establish new fund re-domiciliation mechanisms for existing ... ( read original story ...)